tiprankstipranks

Luc Mainville Insider Profile

4 Followers
Luc Mainville, Interim Chief Executive Officer at Acerus Pharmaceuticals, holds 4.31M shares in ChitogenX (Ticker: CHNXF), holds 875.00K shares in LSL Pharma Group Inc (Ticker: TSE:LSL), holds 3.04M shares in Valeo Pharma (Ticker: VPHIF). Most recently, Luc Mainville Sold ― shares of ChitogenX on Nov 20, 2024 for an estimated value of 3.55K.
tipranks
Luc Mainville

Luc Mainville
Acerus Pharmaceuticals (ASPCQ)
Interim Chief Executive Officer

Ranked #93,664 out of 99,335 Corporate Insiders

Profitable Transactions

20%
4 out of 20 Profitable Transactions

Average Return

-25.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$489K
64.36%
23.38%
12.26%
A breakdown of Luc Mainville's holdings

Insider Roles

LSL Pharma Group Inc
(LSL)
Senior Vice-President & Chief Financial Officer
Valeo Pharma
(VPHIF)
Senior Vice-President & Chief Financial Officer
ChitogenX
(CHNXF)
Chief Financial Officer & Senior Vice-President
Roles that Luc Mainville holds in companies

Most Profitable Insider Trade

Stock:
Acerus Pharmaceuticals
(ASPCQ)
Rating:Informative Buy
Date:Dec 09, 2016 - Dec 09, 2017
Return:+187.80%
The most profitable trade made by Luc Mainville

Luc Mainville's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ASPCQ
Acerus Pharmaceuticals
Dec 28, 2017
Informative Buy
22.66K
$663.57K
ChitogenX
Nov 20, 2024
Chief Financial Officer & Senior Vice-President
Informative Sell
3.55K
$73.32K
Valeo Pharma
Sep 29, 2023
Senior Vice-President & Chief Financial Officer
Uninformative Buy
$139.89K
LSL Pharma Group Inc
Mar 20, 2024
Senior Vice-President & Chief Financial Officer
Informative Buy
350.00K
C$385.00K
List of latest transactions for each holding click on a transaction to see Luc Mainville's performance on stock

Luc Mainville insider profile FAQ

What is the percentage of profitable transactions made by Luc Mainville?
The percentage of profitable transactions made by Luc Mainville is 20%.
    What is the average return per transaction made by Luc Mainville?
    The average return per transaction made by Luc Mainville is -25.80%.
      What stocks does Luc Mainville hold?
      Luc Mainville holds: ASPCQ, CHNXF, VPHIF, TSE:LSL stocks.
        What was Luc Mainville’s latest transaction?
        Luc Mainville latest transaction was an Informative Sell of $3.55K.
          What was Luc Mainville's most profitable transaction?
          Luc Mainville’s most profitable transaction was an Informative Buy of ASPCQ stock on December 9, 2016. The return on the trade was 187.80%.
            What is Luc Mainville's role in Acerus Pharmaceuticals?
            Luc Mainville's role in Acerus Pharmaceuticals is Interim Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.